Search for: "ASTRAZENECA V AUROBINDO"
Results 1 - 16
of 16
Sorted by Relevance
|
Sort by Date
2 Jul 2010, 5:28 am
LP et al v. [read post]
7 Jul 2010, 5:14 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://thinkipstrategy.com/subscribe/ Highlights this week included: Biotechnology patents: Court of Justice of the EU decides against patent theory of Monsanto: Monsanto v Cefetra & Ors (BLOG@IP::JUR) (EPLAW) (IPKat) Prilosec / Losec (Omeprazole) - EU: General Court largely upholds European Commission decision in AstraZeneca v Commission (EPLAW) (IPKat) General… [read post]
6 Jul 2010, 6:03 pm
Highlights this week included: Biotechnology patents: Court of Justice of the EU decides against patent theory of Monsanto: Monsanto v Cefetra & Ors (BLOG@IP::JUR) (EPLAW) (IPKat) Prilosec / Losec (Omeprazole) – EU: General Court largely upholds European Commission decision in AstraZeneca v Commission (EPLAW) (IPKat) General An overview of the ‘Health Impact Fund’ model for accessible medicines (Spicy IP) Pharma pay-and-procure symposium… [read post]
5 May 2010, 4:46 am
Aurobindo Pharma Ltd. et al. [read post]
25 Aug 2010, 12:37 am
Osmotica Pharmaceutical Corp (Patent Docs) Seroquel (Quetiapine) – US: Patent infringement suit filed following Para IV certification: Astrazeneca Pharmaceuticals LP et al. v. [read post]
27 May 2009, 5:27 am
(Patent Office’s rejection of Glivec’s second variant) (Spicy IP) (Spicy IP) Sweden: Anti-counterfeit barcode technology trialled in Sweden (Managing Intellectual Property) US: ACLU, PUBPAT and others file lawsuit challenging constitutionality of patents on human genes associated with breast and ovarian cancer: Association for Molecular Pathology et al v USPTO et al (Inventive Step) (Holman's Biotech IP Blog) US: Biotech sector highly critical of… [read post]
17 Nov 2010, 1:48 am
(FDA Law Blog) Crestor (Rosuvastatin) – US: AstraZeneca defeats Teva’s claim that Crestor infringes Teva’s patent (Orange Book Blog) Crestor (Rosuvastatin) – US: AstraZeneca files patent infringement suit against Watson in response to Para IV certification (Patent Docs) Efexor (Venlafaxine) – Australia: Federal Court blocks generic Efexor-XR: Sigma Pharmaceuticals (Australia) Pty Ltd v Wyeth Australia Pty Ltd (Patentology) (BAZPAT)… [read post]
28 Nov 2008, 12:49 pm
victories in fight for European BRCA patents (Holman's Biotech IP Blog) Europe: European Commission proposes strategy for dealing with rare diseases (Pharmacapsules @ Gowlings) US: Former House Ways and Means Economist claims 7-year data exclusive period is sufficient (Patent Docs) US: Medco predicts follow-on biologics regulatory pathway by 2011 (Patent Docs) US: Even after patent has expired, District Court has jurisdiction to set exclusivity date: In re Omeprazole Patent Litigation… [read post]
25 Jan 2011, 10:58 pm
Cephalon (Patently-O) Seroquel (Quetiapine) – UK: Teva launches High Court action to revoke AstraZeneca’s European patent (IP Factor) Synagis – US: PDL BioPharma Synagis patent invalidated: Medimmune v PDL BioPharma (Patent Docs) Tarka (Trandolapril, Verapamil) – US: Glenmark loses jury verdict in DNJ over Tarka (IPBiz) Wechol (Colesevelam) – US: Watson confirms Welchol oral suspension patent challenge (SmartBrief) [read post]
19 Dec 2008, 1:00 pm
$16.8 million for Alphapharm and Mylan: Takeda v Mylan (Patent Baristas) (Patent Docs) Boniva (Ibandronic acid) – US: Apotex challenges validity of Hoffmann-La Roche’s Boniva patent (Law360) Boniva (Ibandronic acid) – US: Orchid Chemicals & Pharmaceuticals and Orgenus Pharma seek declaratory judgment of invalidity and noninfringement in patent infringement suit brought by Hoffmann-La Roche over Boniva (Law360) Cardizem (Diltiazem) – Antitrust,… [read post]
27 Feb 2009, 5:00 am
Novartis Vaccines and Diagnostics, Inc (Property, intangible) US CAFC reopens DNA detection patent case between Enzo Biochem and former Applera (Law360) US District Court E D California: Antitrust and patent misuse claims tossed in case alleging California Table Grape Commission accepted royalties from growers for invalid patents covering grape varieties (Law360) US: AntiCancer launches second effort to convince federal court that Cambridge Research & Instrumentation infringed three patents… [read post]
15 Dec 2010, 2:17 am
Becton, Dickinson & Co (Intellectual Property Law Blog) US: Regents of the University of California pursue new patent re-examination in District Court (Patents Post Grant Blog) US: Microsoft v i4i, the burden of proof and the pharma sector (PatLit) US: IRS issues notice to implement annual fee on brand drugs (FDA Law Blog) US: Bright ‘orphan’ ideas blossom (FDA Law Blog) US: Amicus briefs in AMP v USPTO (Patent Docs) (Patent Docs) (Patent Docs) US: University of… [read post]
20 Mar 2009, 6:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: Reps Eshoo, Inslee and Barton introduce Pathway for Biosimilars Act (FDA Law Blog) (Patent Docs) (Patent Baristas) (Patent Baristas) (Law360) US: Reps Waxman, Pallone, Deal and Emerson introduce Promoting Innovation and Access to Life-Saving Medicine Act (Intellectual Property Watch) (IPKat) (Patent Docs) EU: Pharma submissions relating to… [read post]
10 Feb 2010, 4:47 pm
Aurobindo Pharma Ltd. et al. [read post]
22 Dec 2010, 3:01 am
Aurobindo Pharma Ltd. et al. [read post]
15 Feb 2008, 9:00 am
: (Spicy IP),USD 20 billion going off-patent: (Patent Circle),Canadian Prices Review Board asserts jurisdiction over products sold in US, but imported into Canada under Special Access Program: (Gowlings),Canadian Court of Appeal affirms decision allowing patent-owner to be joined to proceedings: Cobalt v Pfizer and Pharmascience v Pfizer: (Gowlings),PharmaStem appeals stem cell patent: asks for greater deference to patent examiners:… [read post]
